| Literature DB >> 31515129 |
Neelakshi R Jog1, Micah T McClain2, Latisha D Heinlen1, Timothy Gross1, Rheal Towner3, Joel M Guthridge4, Robert C Axtell1, Gabriel Pardo1, John B Harley5, Judith A James6.
Abstract
Multiple sclerosis (MS) is an autoimmune demyelinating disease with progressive neurodegeneration and complex etiology likely involving genetic and environmental factors. MS has been associated with Epstein Barr virus (EBV) infection, with patients often showing enhanced responses to EBV antigens. To determine whether abnormal EBV nuclear antigen-1 (EBNA-1) humoral immunity can serve as an initiator of autoimmune responses in MS, we investigated the fine specificities of the humoral immune response against EBNA-1 in MS patients using solid phase epitope mapping. Antibodies from MS patients recognized an EBNA-1 epitope spanning amino acids 411-426, previously unknown to be recognized specifically by untreated MS patients. Antibodies against this epitope cross-reacted to myelin basic protein (MBP). Furthermore, animals immunized with this EBNA-1 polypeptide mounted a response against MBP and developed signs of experimental autoimmune encephalitis (EAE). These data support a link between MS and EBV through antibodies that cross-react between EBV proteins and the MBP autoantigen.Entities:
Keywords: EBNA-1; Epstein barr virus; Multiple sclerosis
Mesh：
Substances：
Year: 2019 PMID： 31515129 PMCID： PMC6930324 DOI： 10.1016/j.jaut.2019.102332
Source DB: PubMed Journal: J Autoimmun ISSN： 0896-8411 Impact factor: 14.511